Rhumbline Advisers Purchases 1,310 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO)
Rhumbline Advisers lifted its holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 1.3% during the fourth quarter, HoldingsChannel reports. The firm owned 105,686 shares of the company’s stock after purchasing an additional 1,310 shares during the period. Rhumbline Advisers’ holdings in Akero Therapeutics were worth $2,940,000 as of its most recent filing with […]
